Discrete choice experiments identifying attributes influencing treatment preference in mild asthma

C. Baggott (Wellington, New Zealand), J. Hardy (Wellington, New Zealand), H. Reddel (Sydney, Australia), J. Sparks (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), R. Hancox (Dunedin, New Zealand), P. Hansen (Dunedin, New Zealand), R. Beasley (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand)

Source: International Congress 2019 – Inhalers: adherence and preference
Session: Inhalers: adherence and preference
Session type: Thematic Poster
Number: 4189
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Baggott (Wellington, New Zealand), J. Hardy (Wellington, New Zealand), H. Reddel (Sydney, Australia), J. Sparks (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), R. Hancox (Dunedin, New Zealand), P. Hansen (Dunedin, New Zealand), R. Beasley (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand). Discrete choice experiments identifying attributes influencing treatment preference in mild asthma. 4189

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

The influence of different schemes of basic treatment on functional indices in moderate–severe asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 54s
Year: 2006

Physician‘s perception of pediatric asthma control is influenced by the use of medication
Source: Eur Respir J 2003; 22: Suppl. 45, 365s
Year: 2003

When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



A new perspective on concepts of asthma severity, control and optimum treatment
Source: Eur Respir J 2009; 33: 704-705
Year: 2009


Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018


Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management?
Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine
Year: 2014



Which clinical variables best predict asthma control?
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

The consequences of different definitions in the prediction of asthma in children
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


Population segmentation to identify priority targets for identification and behaviour change interventions in COPD
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011


Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Change in patients asthma control: Possible bias of transition ratings in clinical practice
Source: Eur Respir J 2003; 22: Suppl. 45, 12s
Year: 2003

Which traits to target in asthma? Importance of treatable traits varies depending on desired outcome
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


The factors influencing COPD self-care: a mixed methods study
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018




Identifying tools to investigate outcomes following an exacerbation of COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021



Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002